MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids

Overview

Journal J Am Soc Mass Spectrom

Specialty Chemistry

Date 2017 Dec 7

PMID 29209911

Citations 35

Authors

Xin Liu

Colin Flinders

Shannon M Mumenthaler

Amanda B Hummon

Affiliations

Soon will be listed here.

Abstract

Patient-derived colorectal tumor organoids (CTOs) closely recapitulate the complex morphological, phenotypic, and genetic features observed in in vivo tumors. Therefore, evaluation of drug distribution and metabolism in this model system can provide valuable information to predict the clinical outcome of a therapeutic response in individual patients. In this report, we applied matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to examine the spatial distribution of the drug irinotecan and its metabolites in CTOs from two patients. Irinotecan is a prodrug and is often prescribed as part of therapeutic regimes for patients with advanced colorectal cancer. Irinotecan shows a time-dependent and concentration-dependent permeability and metabolism in the CTOs. More interestingly, the active metabolite SN-38 does not co-localize well with the parent drug irinotecan and the inactive metabolite SN-38G. The phenotypic effect of irinotecan metabolism was also confirmed by a viability study showing significantly reduced proliferation in the drug treated CTOs. MALDI-MSI can be used to investigate various pharmaceutical compounds in CTOs derived from different patients. By analyzing multiple CTOs from a patient, this method could be used to predict patient-specific drug responses and help to improve personalized dosing regimens. Graphical Abstract ᅟ.

Citing Articles

An Innovative Aggregation-Induced Emission-Based NIR Fluorescent Probe for Visualizing Carboxylesterases in Living Cells, Zebrafish, and Tumor-Bearing Mice.

Gao C, Chen D, Liu H, Ma M, Zhang L, Cui H Molecules. 2024; 29(15).

PMID: 39125064 PMC: 11314084. DOI: 10.3390/molecules29153660.

Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.

Jose A, Kulkarni P, Thilakan J, Munisamy M, Malhotra A, Singh J Mol Cancer. 2024; 23(1):50.

PMID: 38461268 PMC: 10924370. DOI: 10.1186/s12943-023-01916-6.

Mass Spectrometry Imaging and Histology for the Analysis of Budding Intestinal Organoids.

Sekera E, Akkaya-Colak K, Lopez A, Mihaylova M, Hummon A Anal Chem. 2024; 96(10):4251-4258.

PMID: 38427328 PMC: 10955551. DOI: 10.1021/acs.analchem.3c05725.

Tissue Microarray Lipidomic Imaging Mass Spectrometry Method: Application to the Study of Alcohol-Related White Matter Neurodegeneration.

Gameiro-Ros I, Noble L, Tong M, Yalcin E, de la Monte S Appl Biosci (Basel). 2024; 2(2):173-193.

PMID: 38384722 PMC: 10880182. DOI: 10.3390/applbiosci2020013.

Quantitative mass spectrometry imaging: therapeutics & biomolecules.

Holbrook J, Kemper G, Hummon A Chem Commun (Camb). 2024; 60(16):2137-2151.

PMID: 38284765 PMC: 10878071. DOI: 10.1039/d3cc05988j.

References

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

Peters W, Allebes W, Jansen P, Poels L, Capel P . Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase. Gastroenterology. 1987; 93(1):162-9. DOI: 10.1016/0016-5085(87)90329-5. View

Walsh A, Castellanos J, Nagathihalli N, Merchant N, Skala M . Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response. Pancreas. 2015; 45(6):863-9. PMC: 4874911. DOI: 10.1097/MPA.0000000000000543. View

Walsh A, Cook R, Sanders M, Arteaga C, Skala M . Drug response in organoids generated from frozen primary tumor tissues. Sci Rep. 2016; 6:18889. PMC: 4703961. DOI: 10.1038/srep18889. View

Iyer L, King C, Whitington P, Green M, Roy S, Tephly T . Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest. 1998; 101(4):847-54. PMC: 508633. DOI: 10.1172/JCI915. View

Daster S, Amatruda N, Calabrese D, Ivanek R, Turrini E, Droeser R . Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment. Oncotarget. 2016; 8(1):1725-1736. PMC: 5352092. DOI: 10.18632/oncotarget.13857. View

Fujii M, Shimokawa M, Date S, Takano A, Matano M, Nanki K . A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. Cell Stem Cell. 2016; 18(6):827-838. DOI: 10.1016/j.stem.2016.04.003. View

Liang X, Xu X, Wang F, Chen X, Li N, Wang C . E-cadherin knockdown increases β-catenin reducing colorectal cancer chemosensitivity only in three-dimensional cultures. Int J Oncol. 2015; 47(4):1517-27. DOI: 10.3892/ijo.2015.3137. View

Shah A, Heaster T, Skala M . Metabolic Imaging of Head and Neck Cancer Organoids. PLoS One. 2017; 12(1):e0170415. PMC: 5242529. DOI: 10.1371/journal.pone.0170415. View

10.

Beyaz S, Mana M, Roper J, Kedrin D, Saadatpour A, Hong S . High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature. 2016; 531(7592):53-8. PMC: 4846772. DOI: 10.1038/nature17173. View

11.

Lukowski J, Weaver E, Hummon A . Analyzing Liposomal Drug Delivery Systems in Three-Dimensional Cell Culture Models Using MALDI Imaging Mass Spectrometry. Anal Chem. 2017; 89(16):8453-8458. PMC: 5567673. DOI: 10.1021/acs.analchem.7b02006. View

12.

Liu X, Hummon A . Mass spectrometry imaging of therapeutics from animal models to three-dimensional cell cultures. Anal Chem. 2015; 87(19):9508-19. PMC: 4766864. DOI: 10.1021/acs.analchem.5b00419. View

13.

Kobayashi T, Yokota H, Ohgiya S, Iwano H, Yuasa A . UDP-glucuronosyltransferase UGT1A7 induced in rat small intestinal mucosa by oral administration of 2-naphthoflavone. Eur J Biochem. 1999; 258(3):948-55. DOI: 10.1046/j.1432-1327.1998.2580948.x. View

14.

Walsh A, Cook R, Sanders M, Aurisicchio L, Ciliberto G, Arteaga C . Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. Cancer Res. 2014; 74(18):5184-94. PMC: 4167558. DOI: 10.1158/0008-5472.CAN-14-0663. View

15.

Candeil L, Gourdier I, Peyron D, Vezzio N, Copois V, Bibeau F . ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer. 2004; 109(6):848-54. DOI: 10.1002/ijc.20032. View

16.

Kyle A, Huxham L, Chiam A, Sim D, Minchinton A . Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. Cancer Res. 2004; 64(17):6304-9. DOI: 10.1158/0008-5472.CAN-04-1099. View

17.

Alexandrov T, Becker M, Guntinas-Lichius O, Ernst G, von Eggeling F . MALDI-imaging segmentation is a powerful tool for spatial functional proteomic analysis of human larynx carcinoma. J Cancer Res Clin Oncol. 2012; 139(1):85-95. DOI: 10.1007/s00432-012-1303-2. View

18.

Alexandrov T, Becker M, Deininger S, Ernst G, Wehder L, Grasmair M . Spatial segmentation of imaging mass spectrometry data with edge-preserving image denoising and clustering. J Proteome Res. 2010; 9(12):6535-46. DOI: 10.1021/pr100734z. View

19.

Kyle A, Huxham L, Yeoman D, Minchinton A . Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Clin Cancer Res. 2007; 13(9):2804-10. DOI: 10.1158/1078-0432.CCR-06-1941. View

20.

Sato T, Stange D, Ferrante M, Vries R, van Es J, van den Brink S . Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology. 2011; 141(5):1762-72. DOI: 10.1053/j.gastro.2011.07.050. View